Founded in 1999, Celadon Laboratories has established itself as the leading developer of web-based software for the design of nucleic acid primers and probes. As part of this commitment, Celadon conducts pioneering research for determining hybridization and positional design rules for modified nucleic acid chemistries. In both of these key areas, Celadon has the same goal: to cure disease through the design of more effective research and therapeutic oligonucleotides.

In 2003, the U.S. National Cancer Institute commissioned Celadon to further develop its state-of-the-art, multi-method primer and probe design platform. Since 2001, Celadon has licensed its software to vendors of proprietary genomic analysis methods to provide fast, easy-to-use, web-based software that facilitates customers' assay design and purchasing process.